PCD Pharma Franchise Opportunities in Kerala with Daksh Diabetes and Cardiac Care
Recent data reveals that Kerala has become India’s diabetes capital, with prevalence more than double the national average. According to the National Family Health Survey (NFHS-6) 2023-24, 31.9% of men and 28.9% of women in Kerala have high blood sugar levels or are on diabetes medication. This marks a sharp rise from 27.0% and 24.8% respectively in NFHS-5. The state leads the country in diabetes prevalence, with nearly one in three adult men now affected.
The burden of hypertension is equally concerning. NFHS-6 data shows 31.9% of women and 36.6% of men have elevated blood pressure or are on medication. A spatial analysis of South India found Kerala exhibiting the highest hypertension prevalence, with significant clustering of cases across districts. A community-based study in Northern Kerala found a diabetes prevalence of 30% and an impaired glucose tolerance prevalence of 47.4%, indicating that nearly half the population is at high risk of developing diabetes.
The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Kerala families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes.
How Daksh is making a Difference in Kerala
1. Affordable, Quality-Assured Medications
Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment.
What this means for Kerala patients:
- Access to WHO-GMP certified medications
- Lower out-of-pocket expenses for lifelong treatments
- No compromise on quality despite affordable pricing
2. Complete Cardiac Care Portfolio
Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs:
| Product Category | Daksh Offerings | Purpose |
| ACE Inhibitors | DORAPIL (Ramipril) | Blood pressure control, heart failure treatment |
| ARBs | CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) | Hypertension management |
| Beta-Blockers | CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) | Heart rate control, heart failure |
| Calcium Channel Blockers | DUPIN (Amlodipine), CLINITAC (Cilnidipine) | Blood pressure, angina |
| Diuretics | TORDAC (Torsemide), FRUSIDIP | Fluid management in heart failure |
| Lipid Management | ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) | Cholesterol control |
3. Complete Diabetic Care Portfolio
For diabetes management, Daksh provides modern therapeutic options including:
| Product Category | Daksh Offerings |
| SGLT2 Inhibitors | DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug |
| DPP-4 Inhibitors | TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) |
| Sulfonylureas | GLIMIDAC (Glimepiride) |
| Biguanides | GLYCODIP SR (Metformin) |
| Combination Therapies | DYFOZIN M, GLIMIDAC MV (triple combination) |
4. Focus on Preventive Care
Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications:
- Liver tonics for medication-induced liver protection
- Calcium supplements for bone health (critical for diabetic patients)
- Vitamin complexes for overall metabolic support
5. Supporting Healthcare Providers across Goa
Daksh works with hospitals, clinics, and pharmacies across Kerala to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses.
With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community.
Popular Locations for PCD Pharma Franchise in Goa
| PCD / Franchise Keywords | Product / Therapy Keywords |
| PCD pharma franchise in Thiruvananthapuram | Cardiac diabetic PCD company in Thiruvananthapuram |
| PCD pharma franchise in Kochi | Cardiac diabetic products in Kochi |
| PCD pharma franchise in Kozhikode | Diabetic cardiac PCD franchise in Kozhikode |
| PCD pharma franchise in Thrissur | Cardiac diabetic PCD company in Thrissur |
| PCD pharma franchise in Kollam | Cardiac diabetic products in Kollam |
| PCD pharma franchise in Kannur | Diabetic cardiac PCD franchise in Kannur |
| PCD pharma franchise in Alappuzha | Cardiac diabetic PCD company in Alappuzha |
| PCD pharma franchise in Palakkad | Cardiac diabetic products in Palakkad |
| PCD pharma franchise in Malappuram | Diabetic cardiac PCD franchise in Malappuram |
| PCD pharma franchise in Kasaragod | Cardiac diabetic PCD company in Kasaragod |
Conclusion
The diabetes and heart disease epidemic in Kerala is not just a statistic—it is a reality affecting millions of families. With the state recording the highest diabetes prevalence in India at 31.9% among men and 28.9% among women, and hypertension affecting over 36% of men, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives.
Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines.
Contact Daksh Diabetic and Cardiac
| Contact Method | Details |
| Office Address | Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India |
| Phone | 📞 +91 93565 60523 📞 +91 78886 02869 |
| enquirypurchase.daksh@gmail.com | |
| Contact us | https://diabetes-cardiac.com/contact-us/ |